gimli
JBCHEPHARM stock analysis context
J B CHEMICALS AND PHARMA Stock Context for AI Screening
J B CHEMICALS AND PHARMA is a mid-cap stock in Healthcare. This page summarizes key screening signals for J B CHEMICALS AND PHARMA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about JBCHEPHARMPrice
₹2,192.60
1M return
+10.86%
3M return
+9.61%
Market cap
₹35,204.10 cr
PE
49.62
ROE
+22.32%
RSI
63.57
Turnover
₹44.70 cr
Why it can matter in screens
- Momentum: JBCHEPHARM is above 50DMA, above 200DMA; RSI is 63.57.
- Returns: 1M +10.86%, 3M +9.61%, 6M +26.77%.
- Liquidity: latest turnover is ₹44.70 cr.
- Valuation: PE 49.62, PB 8.46, ROE +22.32%, ROCE +28.33%.
- Growth: 3Y sales CAGR +16.79%, 3Y profit CAGR +19.61%.
Try these prompts
- Analyze J B CHEMICALS AND PHARMA with valuation, momentum and industry peers
- Compare JBCHEPHARM with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare JBCHEPHARM with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.